Health Care: Drugs

Sanofi SA (SNY: NYSE)

$40.52 -0.14 | -0.34%
12/07/16 - 04:02 PM ET
Company Income Statement
Dec 2015 Dec 2014 Dec 2013 Dec 2012
Sales 38.11B 38.91B 43.21B 47.55B
Cost of Sales 9.60B 10.98B 10.68B 12.54B
Gross Operating Profit 28.51B 27.93B 32.53B 35.01B
Selling, General, and Administrative Expenses 10.76B 10.44B 11.31B 12.36B
Research & Development 5.56B 5.68B 6.36B 6.49B
Operating Income before D & A (EBITDA) 12.20B 11.82B 14.86B 16.17B
Depreciation & Amortization 4.67B 3.99B 7.04B 6.49B
Interest Income 194.61M 233.47M 153.28M 122.99M
Other Income - Net 253.65M 302.79M 1.01B 1.26B
Special Income / Charges -780.62M -330.76M -1.48B -408.65M
Total Income Before Interest Expenses (EBIT) 6.32B 7.54B 7.09B 9.15B
Interest Expense 611.16M 727.18M 840.95M 993.20M
Pre-Tax Income 5.71B 6.82B 6.25B 8.15B
Income Taxes 775.15M 1.48B 1.00B 1.47B
Minority Interest 110.42M 144.71M 218.18M 223.50M
Net Income From Continuing Operations 4.93B 5.34B 5.24B 6.69B
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations 4.93B 5.34B 5.24B 6.69B
Extraordinary Income/Losses -135.57M 142.27M 106.33M 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 4.69B 5.34B 5.13B 6.46B
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
6.58B 6.16B 7.14B 8.61B
Preferred Dividends
Net Income Available To Common 4.93B 5.34B 5.24B 6.69B
Basic EPS from Continuing Ops. 1.85 1.97 1.90 2.45
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations 1.85 1.97 1.90 2.45
Basic EPS from Extraordinary Inc. -0.05 0.05 0.04 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total 1.79 2.03 1.94 2.45
Basic Normalized Net Income/Share 2.46 2.28 2.59 3.15
EPS fr Continuing Ops. 1.83 1.95 1.88 2.43
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. 1.83 1.95 1.88 2.43
EPS fr Extraord. Inc. -0.05 0.05 0.04 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total 1.78 2.01 1.91 2.43
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
2.44 2.25 2.56 3.13
Dividends Paid per Share 1.61 1.91 1.86 1.69

Portfolios with SNY

Latest SNY Headlines from TheStreet

More Financial News for SNY

Press Releases for SNY

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter